Roine Irmeli, Saukkoriipi Annika, Leinonen Maija, Peltola Heikki
Faculty of Health Sciences, University Diego Portales, Santiago, Chile.
Diagn Microbiol Infect Dis. 2009 Jan;63(1):16-23. doi: 10.1016/j.diagmicrobio.2008.09.005. Epub 2008 Nov 6.
Cerebrospinal fluid genome counts were determined by quantitative real-time polymerase chain reaction from 121 children: 36 with Streptococcus pneumoniae and 85 with Haemophilus influenzae meningitis. To examine the interactions of genome count and to determine its prognostic importance, we projected the results against findings on admission and different outcomes. The genome count varied vastly in both meningitides ranging from 0 to 9,250,000/microL. The genome quantity was weakly associated with only some of the patient findings on admission. High counts predicted neurologic (odds ratio [OR]=1.36; 95% confidence interval [CI], 1.09-1.69; P=0.006 for 1 log increase) but not audiologic sequelae. They also predicted death in S .pneumoniae (OR=2.05; 95% CI, 1.08-3.87; P=0.03) but not in H. influenzae meningitis.
通过定量实时聚合酶链反应测定了121名儿童的脑脊液基因组计数:36例为肺炎链球菌脑膜炎,85例为流感嗜血杆菌脑膜炎。为了研究基因组计数的相互作用并确定其预后重要性,我们将结果与入院时的发现及不同结局进行了对比。两种脑膜炎的基因组计数差异很大,范围从0至9250000/微升。基因组数量仅与入院时患者的部分表现存在弱关联。高计数可预测神经功能后遗症(比值比[OR]=1.36;95%置信区间[CI],1.09 - 1.69;每增加1个对数,P = 0.006),但不能预测听力后遗症。高计数还可预测肺炎链球菌脑膜炎患者的死亡(OR = 2.05;95% CI,1.08 - 3.87;P = 0.03),但不能预测流感嗜血杆菌脑膜炎患者的死亡。